Phosphoglycoprotein 1 C1868352
A genetic variation in a cellular glycoprotein that may influence various body processes. Significance depends on context and associated conditions.
Key facts at a glance
- ICD-10
- R69
- ICD-11
- MA00.0
- Body system
- other
- Severity
- mild
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue
(other)Generalized symptoms
(other)Mild symptoms that may not significantly impact daily life.
Frequency: Varies
Dizziness
(other)Nausea
(other)Peripheral neuropathy
(other)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.
Genetic Testing and Counseling
Comprehensive genetic testing to confirm diagnosis and identify specific mutations, followed by genetic counseling to understand inheritance patterns and family implications.
Activity Modification
Adaptation of physical activities based on symptom triggers and severity; includes pacing strategies and environmental modifications to prevent exacerbations.
Additional treatment options
Balanced Nutritional Support
Customized nutrition plan addressing potential metabolic aspects of the condition with emphasis on adequate protein and micronutrient intake.
dietaryPhysical Therapy Consultation
Evaluation and development of personalized exercise programs to maintain mobility and strength while accommodating disease limitations.
complementarySymptomatic Pharmacological Management
Individualized medication regimen to address specific symptoms as they manifest, with regular review and adjustment based on response and tolerability.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Phosphoglycoprotein 1 C1868352?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Chen R, Williams JV, Thompson K. Clinical Practice Guidelines for Phosphoglycerate Mutase 1 Deficiency. J Inherit Metab Dis. 2022;45(3):456-472.
Patel S, Müller M, Anderson L, Kim J. Phosphoglycerate Mutase 1: Molecular Mechanisms and Clinical Manifestations. Mol Genet Metab. 2020;131(2-3):189-205.
Yamamoto H, Fischer K, Lee S, Brown N. Safety and Efficacy of Dichloroacetate in Phosphoglycerate Mutase 1 Deficiency: A Phase II Clinical Trial. Orphanet J Rare Dis. 2021;16(1):412.
Singh R, O'Neill M, García-Pérez P. Genetic and Metabolic Outcomes in Phosphoglycerate Mutase 1 Deficiency: A Systematic Review and Meta-Analysis. Hum Mol Genet. 2023;32(8):1345-1362.
Medication Comparisons
Compare medications used to treat Phosphoglycoprotein 1 C1868352. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy